Does PIOGLITAZONE Cause Bladder transitional cell carcinoma? 398 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 398 reports of Bladder transitional cell carcinoma have been filed in association with PIOGLITAZONE (PIOGLITAZONE). This represents 3.4% of all adverse event reports for PIOGLITAZONE.
398
Reports of Bladder transitional cell carcinoma with PIOGLITAZONE
3.4%
of all PIOGLITAZONE reports
55
Deaths
16
Hospitalizations
How Dangerous Is Bladder transitional cell carcinoma From PIOGLITAZONE?
Of the 398 reports, 55 (13.8%) resulted in death, 16 (4.0%) required hospitalization, and 11 (2.8%) were considered life-threatening.
Is Bladder transitional cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PIOGLITAZONE. However, 398 reports have been filed with the FAERS database.
What Other Side Effects Does PIOGLITAZONE Cause?
Bladder cancer (7,295)
Death (976)
Dyspnoea (249)
Drug ineffective (230)
Weight increased (219)
Hypoglycaemia (217)
Cardiac failure (195)
Cardiac failure congestive (194)
Drug hypersensitivity (182)
Oedema peripheral (166)
What Other Drugs Cause Bladder transitional cell carcinoma?
ADALIMUMAB (96)
METHOTREXATE (95)
RITUXIMAB (74)
TOCILIZUMAB (68)
INFLIXIMAB (63)
SULFASALAZINE (55)
HYDROXYCHLOROQUINE (50)
PREDNISONE (48)
LENALIDOMIDE (42)
RANITIDINE (41)
Which PIOGLITAZONE Alternatives Have Lower Bladder transitional cell carcinoma Risk?
PIOGLITAZONE vs PIPAMPERONE
PIOGLITAZONE vs PIPERACILLIN
PIOGLITAZONE vs PIPERACILLIN\TAZOBACTAM
PIOGLITAZONE vs PIRACETAM
PIOGLITAZONE vs PIRARUBICIN